메뉴 건너뛰기




Volumn 30, Issue 2, 2012, Pages 131-135

Predicting prostate cancer many years before diagnosis: How and why?

Author keywords

Early detection of cancer; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 84859440741     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0795-8     Document Type: Article
Times cited : (13)

References (18)
  • 1
    • 34447340514 scopus 로고    scopus 로고
    • Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: "what has been will be again, what has been done will be done again; there is nothing new under the sun." ECCLESIASTES 1:9
    • doi:10.1093/ije/dym056
    • Thompson IM, Lucia MS, Tangen CM (2007) Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: "what has been will be again, what has been done will be done again; there is nothing new under the sun." ECCLESIASTES 1: 9. Int J Epidemiol 36(2): 287-289. doi: 10. 1093/ije/dym056.
    • (2007) Int J Epidemiol , vol.36 , Issue.2 , pp. 287-289
    • Thompson, I.M.1    Lucia, M.S.2    Tangen, C.M.3
  • 2
    • 4644287961 scopus 로고    scopus 로고
    • Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study
    • doi:10.1093/jnci/djh259
    • Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC (2004) Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 96(18): 1358-1367. doi: 10. 1093/jnci/djh259.
    • (2004) J Natl Cancer Inst , vol.96 , Issue.18 , pp. 1358-1367
    • Potosky, A.L.1    Davis, W.W.2    Hoffman, R.M.3    Stanford, J.L.4    Stephenson, R.A.5    Penson, D.F.6    Harlan, L.C.7
  • 4
    • 0026522840 scopus 로고
    • Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
    • Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267(16): 2215-2220.
    • (1992) Jama , vol.267 , Issue.16 , pp. 2215-2220
    • Carter, H.B.1    Pearson, J.D.2    Metter, E.J.3    Brant, L.J.4    Chan, D.W.5    Andres, R.6    Fozard, J.L.7    Walsh, P.C.8
  • 6
    • 0027972144 scopus 로고
    • Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer
    • Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J (1994) Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet 344(8937): 1594-1598.
    • (1994) Lancet , vol.344 , Issue.8937 , pp. 1594-1598
    • Stenman, U.H.1    Hakama, M.2    Knekt, P.3    Aromaa, A.4    Teppo, L.5    Leinonen, J.6
  • 7
    • 0028801975 scopus 로고
    • A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer
    • Gann PH, Hennekens CH, Stampfer MJ (1995) A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 273(4): 289-294.
    • (1995) Jama , vol.273 , Issue.4 , pp. 289-294
    • Gann, P.H.1    Hennekens, C.H.2    Stampfer, M.J.3
  • 8
    • 31844447749 scopus 로고    scopus 로고
    • Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C
    • doi:10.1373/clinchem.2005.050641
    • Ulmert D, Becker C, Nilsson JA, Piironen T, Bjork T, Hugosson J, Berglund G, Lilja H (2006) Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C. Clin Chem 52(2): 235-239. doi: 10. 1373/clinchem. 2005. 050641.
    • (2006) Clin Chem , vol.52 , Issue.2 , pp. 235-239
    • Ulmert, D.1    Becker, C.2    Nilsson, J.A.3    Piironen, T.4    Bjork, T.5    Hugosson, J.6    Berglund, G.7    Lilja, H.8
  • 9
    • 79952133146 scopus 로고    scopus 로고
    • Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50
    • doi:10.1002/cncr.25568
    • Lilja H, Cronin AM, Dahlin A, Manjer J, Nilsson PM, Eastham JA, Bjartell AS, Scardino PT, Ulmert D, Vickers AJ (2011) Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50. Cancer 117(6): 1210-1219. doi: 10. 1002/cncr. 25568.
    • (2011) Cancer , vol.117 , Issue.6 , pp. 1210-1219
    • Lilja, H.1    Cronin, A.M.2    Dahlin, A.3    Manjer, J.4    Nilsson, P.M.5    Eastham, J.A.6    Bjartell, A.S.7    Scardino, P.T.8    Ulmert, D.9    Vickers, A.J.10
  • 13
    • 13844264517 scopus 로고    scopus 로고
    • Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/ml or less in a population-based screening setting? (ERSPC, section Rotterdam)
    • doi:10.1016/j.urology.2004.09.046
    • Roobol MJ, Roobol DW, Schroder FH (2005) Is additional testing necessary in men with prostate-specific antigen levels of 1. 0 ng/ml or less in a population-based screening setting? (ERSPC, section Rotterdam). Urology 65(2): 343-346. doi: 10. 1016/j. urology. 2004. 09. 046.
    • (2005) Urology , vol.65 , Issue.2 , pp. 343-346
    • Roobol, M.J.1    Roobol, D.W.2    Schroder, F.H.3
  • 14
    • 79952282237 scopus 로고    scopus 로고
    • Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam
    • doi:10.1016/j.eururo.2011.01.001
    • Bul M, van Leeuwen PJ, Zhu X, Schroder FH, Roobol MJ (2011) Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3. 0 ng/ml who are participating in ERSPC Rotterdam. Eur Urol 59(4): 498-505. doi: 10. 1016/j. eururo. 2011. 01. 001.
    • (2011) Eur Urol , vol.59 , Issue.4 , pp. 498-505
    • Bul, M.1    van Leeuwen, P.J.2    Zhu, X.3    Schroder, F.H.4    Roobol, M.J.5
  • 16
    • 47249150529 scopus 로고    scopus 로고
    • Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) study
    • doi:10.1002/ijc.23591
    • Ahn J, Moslehi R, Weinstein SJ, Snyder K, Virtamo J, Albanes D (2008) Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) study. Int J Cancer 123(5): 1154-1159. doi: 10. 1002/ijc. 23591.
    • (2008) Int J Cancer , vol.123 , Issue.5 , pp. 1154-1159
    • Ahn, J.1    Moslehi, R.2    Weinstein, S.J.3    Snyder, K.4    Virtamo, J.5    Albanes, D.6
  • 17
    • 77955309014 scopus 로고    scopus 로고
    • Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members
    • doi:10.1016/j.eururo.2010.02.002
    • Brandt A, Bermejo JL, Sundquist J, Hemminki K (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 58(2): 275-280. doi: 10. 1016/j. eururo. 2010. 02. 002.
    • (2010) Eur Urol , vol.58 , Issue.2 , pp. 275-280
    • Brandt, A.1    Bermejo, J.L.2    Sundquist, J.3    Hemminki, K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.